Blount Sally E.

SEC source: 0001537286-26-000002 · form4-04282026_100406.xml · nonDerivative · entry 1

Blount Sally E. · CIK 0001537286 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,344

F1 · shares: Restricted stock unit award granted under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). The award will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

SEC source: 0001415889-25-011837 · form4-05022025_090502.xml · nonDerivative · entry 1

Blount Sally E. · CIK 0001537286 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,058

SEC source: 0001415889-25-011518 · form4-04292025_090438.xml · nonDerivative · entry 1

Blount Sally E. · CIK 0001537286 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,658

F1 · shares: These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

SEC source: 0001415889-24-011790 · form4-04302024_090442.xml · nonDerivative · entry 1

Blount Sally E. · CIK 0001537286 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,023

F1 · shares: These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

SEC source: 0001415889-23-007128 · form4-05022023_110553.xml · nonDerivative · entry 1

Blount Sally E. · CIK 0001537286 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,157

F1 · shares: These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

SEC source: 0001415889-22-004547 · form4-05032022_020549.xml · nonDerivative · entry 1

Blount Sally E. · CIK 0001537286 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,341

F1 · shares: These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

SEC source: 0001567619-21-011630 · doc1.xml · derivative · entry 1

Blount Sally E. · CIK 0001537286 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,071

Underlying: Common Stock · 476 shares

Expires not disclosed

F1 · derivative.exercise_date: Represents a grant of 476 restricted stock units. The reporting person has elected to defer receipt of the restricted stock units until the reporting person's retirement or termination from the Board of Directors, subject to vesting requirements.

F1 · derivative.expiration_date: Represents a grant of 476 restricted stock units. The reporting person has elected to defer receipt of the restricted stock units until the reporting person's retirement or termination from the Board of Directors, subject to vesting requirements.

SEC source: 0001415889-21-002156 · form4-04272021_040402.xml · nonDerivative · entry 1

Blount Sally E. · CIK 0001537286 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,739

F1 · shares: These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

SEC source: 0001567619-20-012634 · form4.xml · nonDerivative · entry 1

Blount Sally E. · CIK 0001537286 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,239

SEC source: 0001567619-20-011713 · doc1.xml · derivative · entry 1

Blount Sally E. · CIK 0001537286 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 595

Underlying: Common Stock · 595 shares

Expires not disclosed

F1 · derivative.exercise_date: Represents a grant of 595 restricted stock units. The reporting person has elected to defer receipt of the restricted stock units until the reporting person's retirement or termination from the Board of Directors, subject to vesting requirements.

F1 · derivative.expiration_date: Represents a grant of 595 restricted stock units. The reporting person has elected to defer receipt of the restricted stock units until the reporting person's retirement or termination from the Board of Directors, subject to vesting requirements.

SEC source: 0001179110-20-005180 · edgar.xml · nonDerivative · entry 1

Blount Sally E. · CIK 0001537286 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,240

F1 · shares: These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

SEC source: 0001104659-19-043751 · a4.xml · nonDerivative · entry 1

Blount Sally E. · CIK 0001537286 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,266

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.3633 to $87.9102, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

SEC source: 0001567619-19-013888 · doc1.xml · nonDerivative · entry 1

Blount Sally E. · CIK 0001537286 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 989

SEC source: 0001567619-19-012932 · doc1.xml · nonDerivative · entry 1

Blount Sally E. · CIK 0001537286 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,304

F1 · shares: Represents a grant of 445 restricted stock units, vesting 100% on 6/6/2020.

SEC source: 0001179110-19-005309 · edgar.xml · nonDerivative · entry 1

Blount Sally E. · CIK 0001537286 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,766

F1 · shares: These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

SEC source: 0001140361-18-027715 · doc1.xml · nonDerivative · entry 1

Blount Sally E. · CIK 0001537286 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 859

F1 · shares: Represents a grant of 587 restricted stock units, vesting 100% on 6/6/2019.

SEC source: 0001179110-18-006024 · edgar.xml · nonDerivative · entry 1

Blount Sally E. · CIK 0001537286 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,525

F1 · shares: These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

SEC source: 0001140361-17-045344 · doc1.xml · nonDerivative · entry 1

Blount Sally E. · CIK 0001537286 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 272

F1 · shares: Represents a grant of 272 restricted stock units, vesting 100% on 12/6/2018.

SEC source: 0001179110-17-006404 · edgar.xml · nonDerivative · entry 1

Blount Sally E. · CIK 0001537286 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,580

F1 · shares: These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

F1 · price: These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

SEC source: 0001179110-16-031089 · edgar.xml · nonDerivative · entry 1

Blount Sally E. · CIK 0001537286 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,143

SEC source: 0001179110-16-023671 · edgar.xml · nonDerivative · entry 1

Blount Sally E. · CIK 0001537286 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,043

F1 · shares: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

F1 · price: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

SEC source: 0001179110-15-006739 · edgar.xml · nonDerivative · entry 1

Blount Sally E. · CIK 0001537286 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,244

F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

F1 · price: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

SEC source: 0001179110-14-007330 · edgar.xml · nonDerivative · entry 1

Blount Sally E. · CIK 0001537286 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,451

F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

F1 · price: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

SEC source: 0001179110-13-007417 · edgar.xml · nonDerivative · entry 1

Blount Sally E. · CIK 0001537286 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,916

F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

F1 · price: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

SEC source: 0001179110-12-007453 · edgar.xml · nonDerivative · entry 1

Blount Sally E. · CIK 0001537286 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,819

F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

F1 · price: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).